The Valley Desk

ReviewExpert opinion on therapeutic patentsPublished

Bruton's tyrosine kinase (BTK) inhibitors: an updated patent review (2019-2024)

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bryn Mawr College. Affiliation source

Publication record

Type
Review
Venue
Expert opinion on therapeutic patents
Published
Subject terms
Animals; Humans; Neoplasms; Autoimmune Diseases; Protein Kinase Inhibitors; Drug Design; Patents as Topic; Drug Development; Agammaglobulinaemia Tyrosine Kinase; Patent; Targeted Therapy; Small Molecule
PubMed ID
40878081
Added to directory
Source checked

Report a correction or request removal